C21 Investments Inc.
General ticker "CXXIF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $27.3M (TTM average)
C21 Investments Inc. follows the US Stock Market performance with the rate: 49.6%.
Estimated limits based on current volatility of 3.4%: low 0.31$, high 0.33$
Factors to consider:
- Total employees count: 33 as of 2025
- Price in estimated range
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-01-31 to 2026-01-30
- 2024-01-31 to 2025-01-30 estimated range: [0.18$, 0.47$]
- 2025-01-30 to 2026-01-30 estimated range: [0.13$, 0.37$]
Financial Metrics affecting the CXXIF estimates:
- Positive: with PPE of -12.8 at the end of fiscal year the price was low
- Positive: -3.60 < Operating profit margin, % of 5.20
- Positive: Operating cash flow per share per price, % of 13.93 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 56.94 <= 63.39
- Negative: negative Net income
- Positive: Inventory ratio change, % of -4.07 <= -0.75
- Positive: Industry inventory ratio change (median), % of -0.26 <= -0.15
- Positive: Interest expense per share per price, % of 0.08 <= 0.79
Short-term CXXIF quotes
Long-term CXXIF plot with estimates
Financial data
| YTD | 2022-01-31 | 2023-01-31 | 2024-01-31 |
|---|---|---|---|
| Operating Revenue | $32.98MM | $28.89MM | $28.29MM |
| Operating Expenses | $23.23MM | $24.93MM | $26.81MM |
| Operating Income | $9.76MM | $3.96MM | $1.47MM |
| Non-Operating Income | $7.38MM | $0.24MM | $-1.21MM |
| Interest Expense | $1.31MM | $0.46MM | $0.04MM |
| Income(Loss) | $17.13MM | $4.19MM | $0.26MM |
| Taxes | $4.93MM | $2.81MM | $3.48MM |
| Profit(Loss)* | $9.96MM | $0.29MM | $-3.31MM |
| Stockholders Equity | $34.98MM | $34.32MM | $31.05MM |
| Inventory | $4.05MM | $4.17MM | $2.86MM |
| Assets | $61.85MM | $58.31MM | $54.53MM |
| Operating Cash Flow | $6.84MM | $5.90MM | $5.90MM |
| Capital expenditure | $2.56MM | $0.44MM | $0.05MM |
| Investing Cash Flow | $-1.39MM | $-0.39MM | $-0.39MM |
| Financing Cash Flow | $-7.84MM | $-6.68MM | $-6.68MM |
| Earnings Per Share** | $0.08 | $0.00 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.